Nicola Curtin

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Frank Tadashi Zenke

Chief Scientific Officer

SWITZERLAND

View details

kevin james marchbank

Professor of Complement Biology

Newcastle University

UNITED KINGDOM

View details

Santu Saha

Teesside University

UNITED KINGDOM

View details

yvette drew

Associate Professor

The University of British Columbia

CANADA

View details

Isabel Pappworth

Newcastle University

UNITED KINGDOM

View details

Sweta Sharma Saha

Teesside University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicola Curtin

Research Interests

Explore related searches

Contact this professor

Articles (11)

DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

Targeting the DNA damage response for cancer therapy

25 years of ERMM

Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy

Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling

The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of Response

Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells

Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer

Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting

Collaborators (6)

Frank Tadashi Zenke

kevin james marchbank

Santu Saha

yvette drew

Isabel Pappworth

Sweta Sharma Saha

Make your next move.